|Day Low/High||187.56 / 192.47|
|52 Wk Low/High||123.00 / 178.68|
Jim Cramer takes a look at New Relic, Edwards Lifesciences, Aphria, NovaGold Resources, Insperity and more.
Disruptors are among the biggest winners, says Jim Cramer. Companies like Apple and Kraft Heinz need to re-imagine their companies in bold, meaningful and even radical ways.
IRVINE, Calif., March 11, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced two strategic transactions involving...
NEW ORLEANS, Feb. 15, 2019 /PRNewswire/ -- Former Attorney General of Louisiana Charles C.
NEW YORK, Feb. 12, 2019 /PRNewswire/ -- Rowley Law PLLC is investigating potential claims against CAS Medical Systems, Inc.
Shares jump nearly 8% following agreement to pay rival Boston Scientific Corp. 4180 million to settle long-standing patent disputes.
All Patent Litigation Between the Companies to be Dismissed
The most recent short interest data has been released for the 12/14/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
Jim Cramer weighs in on Walmart, AES, IBM and more.
Conflicting data about the economy should give the Federal Reserve pause.
Jim Cramer weighs in on Dell Technologies, Vail Resorts, Mastercard, CyberArk, iRobot, Marriott Vacations, TherapeuticsMD, Edwards Lifesciences.
IRVINE, Calif., Oct.
Straying from these names could land you in quicksand as the 4th quarter begins.
Cumulative work of 60 non-profit partners now expected to reach 1.5 million by 2020
Biotechs are known for wild tears. Investors, you'll want to consider these drug makers.
From purses and parcels to steel, Jim Cramer and Rob Moreno parse the moves of four stocks that are poised for big moves higher.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.